UY38216A - Inhalador - Google Patents

Inhalador

Info

Publication number
UY38216A
UY38216A UY38216A UY38216A UY38216A UY 38216 A UY38216 A UY 38216A UY 38216 A UY38216 A UY 38216A UY 38216 A UY38216 A UY 38216A UY 38216 A UY38216 A UY 38216A
Authority
UY
Uruguay
Prior art keywords
capsule
main body
inhaler
chamber
portions
Prior art date
Application number
UY38216A
Other languages
English (en)
Inventor
Mercandelli Alberto
Original Assignee
Pharmadevices S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmadevices S R L filed Critical Pharmadevices S R L
Publication of UY38216A publication Critical patent/UY38216A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0023—Mouthpieces therefor retractable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0043—Non-destructive separation of the package, e.g. peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un inhalador para una sustancia en polvo contenida en una cápsula que comprende un cuerpo principal dividido en dos porciones que definen conjuntamente por lo menos una parte de la cámara de la cápsula, adaptada para retener una primera parte de la cápsula respectiva. Las dos porciones del cuerpo están articuladas entre sí de manera de rotar entre una posición del cuerpo principal cerrado que retiene una primera parte de la cápsula en su correspondiente primera parte de la cámara y una posición del cuerpo principal abierto adecuada para permitir la expulsión de la primera parte de la cápsula.
UY38216A 2018-05-09 2019-05-06 Inhalador UY38216A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2018/000066 WO2019215767A1 (en) 2018-05-09 2018-05-09 Inhaler device

Publications (1)

Publication Number Publication Date
UY38216A true UY38216A (es) 2019-10-01

Family

ID=63042078

Family Applications (1)

Application Number Title Priority Date Filing Date
UY38216A UY38216A (es) 2018-05-09 2019-05-06 Inhalador

Country Status (21)

Country Link
US (1) US12036357B2 (es)
EP (1) EP3790612B1 (es)
JP (1) JP7146309B2 (es)
KR (1) KR102631314B1 (es)
CN (1) CN112088026B (es)
AR (1) AR114870A1 (es)
BR (1) BR112020022671A2 (es)
CA (1) CA3098652A1 (es)
DK (1) DK3790612T3 (es)
EA (1) EA039317B1 (es)
ES (1) ES2913436T3 (es)
HR (1) HRP20220575T1 (es)
IL (1) IL278501B2 (es)
LT (1) LT3790612T (es)
MX (1) MX2020011831A (es)
PL (1) PL3790612T3 (es)
PT (1) PT3790612T (es)
RS (1) RS63159B1 (es)
SI (1) SI3790612T1 (es)
UY (1) UY38216A (es)
WO (1) WO2019215767A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4288132A1 (en) * 2021-02-16 2023-12-13 Knightpoint, LLC Capsule inhalers and methods of using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598081A (en) * 1977-02-10 1981-09-16 Allen & Hanburys Ltd Inhaler device for dispensing medicaments
AU545574B2 (en) * 1979-10-30 1985-07-18 Riker Laboratories, Inc. Breath actuated devices for adminstering powdered medicaments
ES8206980A1 (es) * 1980-10-30 1982-09-01 Riker Laboratories Inc Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
GB9216038D0 (en) * 1992-07-28 1992-09-09 Bespak Plc Dispensing apparatus for powdered medicaments
US7305986B1 (en) * 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
JP4582582B2 (ja) * 2005-03-31 2010-11-17 株式会社吉野工業所 粉体吸引器
WO2009091780A2 (en) * 2008-01-14 2009-07-23 Dr. Reddy's Laboratories Ltd. Device for inhaling powdered medicaments
FR2962338B1 (fr) * 2010-07-07 2012-08-03 Valois Sas Inhalateur de poudre seche.
FR2962342B1 (fr) * 2010-07-07 2013-02-15 Valois Sas Inhalateur de poudre seche.
FR2968566B1 (fr) * 2010-12-14 2013-10-18 Valois Sas Inhalateur de poudre seche.
FR2977498B1 (fr) * 2011-07-05 2015-10-02 Valois Sas Inhalateur de poudre seche.
UA111442C2 (uk) * 2012-10-02 2016-04-25 Кмс Ді Колозіо Мауро Інгаляційний пристрій
JP6499288B2 (ja) * 2014-11-26 2019-04-10 ヴェクトュラ・デリヴァリー・ディヴァイスィズ・リミテッド ドライパウダー吸入器

Also Published As

Publication number Publication date
PL3790612T3 (pl) 2022-05-16
JP7146309B2 (ja) 2022-10-04
IL278501B1 (en) 2023-06-01
EA202092568A1 (ru) 2021-02-26
HRP20220575T1 (hr) 2022-06-10
MX2020011831A (es) 2021-02-18
CA3098652A1 (en) 2019-11-14
IL278501A (es) 2020-12-31
CN112088026A (zh) 2020-12-15
US20210316090A1 (en) 2021-10-14
SI3790612T1 (sl) 2022-06-30
KR102631314B1 (ko) 2024-01-29
BR112020022671A2 (pt) 2021-02-09
KR20210008387A (ko) 2021-01-21
ES2913436T3 (es) 2022-06-02
EP3790612B1 (en) 2022-02-16
DK3790612T3 (da) 2022-05-02
AR114870A1 (es) 2020-10-28
WO2019215767A9 (en) 2019-12-19
JP2021529638A (ja) 2021-11-04
IL278501B2 (en) 2023-10-01
EA039317B1 (ru) 2022-01-12
EP3790612A1 (en) 2021-03-17
WO2019215767A1 (en) 2019-11-14
CN112088026B (zh) 2022-07-01
LT3790612T (lt) 2022-05-10
US12036357B2 (en) 2024-07-16
PT3790612T (pt) 2022-05-04
RS63159B1 (sr) 2022-05-31

Similar Documents

Publication Publication Date Title
DOP2017000271A (es) Métodos de acondicionamiento de pacientes para tratamiento con linfocitos t
UY38160A (es) Partículas implantables y métodos relacionados
CL2016003109A1 (es) Una máscara de ventilación de gas, que comprende una máscara nasal y una máscara bucal, conectadas de manera separable entre sí, en la que unas cámaras nasal y oral están conectadas entre sí a través de un tabique de cierre automático o válvula.
CL2018000706A1 (es) Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer.
PE20181095A1 (es) Envase blister
CL2015002546A1 (es) Derivados 3-fenilpropilamina sustituidos para el tratamiento de enfermedades y trastornos oftálmicos
BR112017001746A2 (pt) bolsa
AR102265A4 (es) Empaque exterior separable para artículos absorbentes para el cuidado personal
EP3706774A4 (en) GLP-2 ANALOGUES AND PEPTIBODIES FOR USE BEFORE, DURING OR AFTER SURGICAL PROCEDURE
CL2018000739A1 (es) Terapia adjuntiva con 25-hidroxi vitamina d y artículos de la misma.
CL2016002607A1 (es) Procedimiento para preparar una preparación farmacéutica de acetato de glatiramer y manitol en un contenedor adecuado que comprende las etapas de obtener una solución acuosa de acetato de glatiramer y manitol, filtración de la solución entre 0 y 17,5 grado celsius y llenado del contenedor. pct
PT3590971T (pt) Polisulfato de pentosano, composição farmacêutica e anticoagulante
CL2020001050A1 (es) Un filtro para un artículo para fumar o un producto generador de aerosol.
CO2017012645A2 (es) Agente antihipertensivo que comprende s-1-propenilcisteína o una sal del mismo como ingrediente activo
UY38216A (es) Inhalador
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
CL2016003381A1 (es) Casquillo para detonación
BR112018014923A2 (pt) aparelho de alojamento de filtro de descolamento
RU2016142424A (ru) Способ хирургического лечения рецидивирующего макулярного разрыва
BR112017016190A2 (pt) aparelho de vedação, aparelho de válvula rotativa modular e motor
AR105413A1 (es) Composición farmacéutica para el tratamiento de enfermedades gastrointestinales
CL2019003172A1 (es) Brimonidina destinada al uso y diseño de ensayos clínicos para la atrofia geográfica debido a una degeneración macular asociada a la edad.
BR112017001375A2 (pt) agente farmacêutico
EA202091403A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis